网站首页杂志简介编委会投稿须知期刊订阅过刊浏览广告合作在线留言联系我们
位置:首页 >> 电子期刊 >> 正文
肝细胞肝癌的发病机制与治疗进展
作者: 陈曦钟国超龚建平2 
Authors: Chen Xi1, Zhong Guochao2, Gong Jianping2 
单位: 1重庆市武隆区人民医院普外科 408500;2重庆医科大学第二医院肝胆外科 400010 通信作者:龚建平, Email: gongjianping11@126.com
Units: 1Department of General Surgery, Wulong People′s Hospital of Chongqing, Chongqing 408500, China; 2 Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China Corresponding author: Gong Jianping, Email: gongjianping11@126.com
关键词: 癌, 肝细胞; 靶向治疗; 进展
Keywords: Carcinoma, hepatocellular; Target therapy; Research progress
分类号:
出版年,卷(期):页码:2020,47(3):202-206
摘要:

 全球肝细胞肝癌(HCC)的疾病负担正逐年增加。根据临床和组织病理特征,HCC可分为增生型和非增生型2 类。HCC的发生发展与遗传和表观遗传改变密切相关,然而其发病机制尚不明确。CT/MRI是临床上常用的HCC影像学诊断方法。巴塞罗那临床肝癌分期系统是目前使用最为广泛的分期系统。HCC的治疗手段包括外科手术、肝移植、消融治疗、经动脉疗法和全身疗法。本文将着重阐述HCC发病机制和治疗方面的研究进展。

 The global disease burden of hepatocellular carcinoma (HCC) is increasing gradually. HCC can be categorized into proliferation and non-proliferation classes. The occurrence and development of HCC are closely associated with both genetic and epigenetic changes. However, the underlying mechanisms remain unclear. CT/MRI is the most commonly used imaging modality for diagnosis of HCC. Barcelona clinic liver cancer staging system is widely used to stage HCC worldwide. The treatment options of HCC include surgery, liver transplantation, radiofrequency ablation, transcatheter arterial chemoembolization and systematic therapy. This review will focus on the progress in mechanisms and treatments of HCC.

基金项目:
作者简介:
参考文献:
服务与反馈:
文章下载】 【加入收藏
    广告合作

地址:北京市西城区永安路95号《国际外科学杂志》编辑部

 

邮编:100050               电话:010-63138570 

 

传真:010-63139265   Email: gjwkx@263.net 

 

投稿网址:http://www.cma.org.cn/html/main/index.html